FOXP3 and colitis: Our results raise the notion that the numerical enlargement of the conventional CD4+CD25−Foxp3− T cell pool, presumably bringing higher diversification of T cell repertoire in parallel, may be beneficial for colitis suppression as a consequence of improved B cell-driven peripheral conversion to CD4+Foxp3+ regulatory T cells.